# Sodium Nitroprusside

NDC: 71839-120
Generic name: Sodium Nitroprusside
Labeler / Manufacturer: BE Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20210712

FDA application: ANDA214971

## Active ingredients

- SODIUM NITROPRUSSIDE: 50 mg/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71839-120"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71839-120
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01841345-bed3-458f-8e99-911fbd286512